For more than 22 years, Clin Assess is a CRO that pursue its work with great passion. They work on commercial studies including those with a high patient number.
Customers appreciate their medical background, their expertise, and the precision in which they achieve their goals and realise all phases of the clinical trial with pinpoint accuracy.
They rely on clear project communication with interactive feedback, provide individual support for their customers and accompany them step by step from the beginning and through all stages of the project.
Their employees are specialists from the pharmaceutical industry, contract research and the clinical sector. They have special expertise in the fields of oncology, cardiovascular diseases, infectious diseases, immunotherapy, personalised medicine and diseases of the central nervous system.
Learn more: www.clinassess.de
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]